Ivana Zimonjić

Dr. Ivana Zimonjić

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 October 2024 in International Journal of Clinical Pharmacy
Verified
Journal Article
Closed access
PDF file
IZIvana Zimonjić
Ivana Zimonjić
VMValentina Marinković
Valentina Marinković
José Joaquin MiraJosé Joaquin Mira
José Joaquin Mira
BDBorivoje-Boris Djokic
Borivoje-Boris Djokic
MOMarina Odalović
Marina Odalović

13 February 2025 in International Journal of Clinical Pharmacy
Verified
Journal Article
Closed access
IZIvana Zimonjić
Ivana Zimonjić
VMValentina Marinković
Valentina Marinković
José Joaquin MiraJosé Joaquin Mira
José Joaquin Mira
BKBojana Knezevic
Bojana Knezevic
BDBorivoje-Boris Djokic
Borivoje-Boris Djokic
MOMarina Odalović
Marina Odalović

15 August 2025 in International Journal of Clinical Pharmacy
Verified
Journal Article
Closed access
IZIvana Zimonjić
Ivana Zimonjić
VMValentina Marinković
Valentina Marinković
DJDragana Jocić
Dragana Jocić
LDLazar Radivoje Dražeta
Lazar Radivoje Dražeta
MOMarina Odalović
Marina Odalović

20 August 2025 in Pharmacy
Verified
Journal Article
Open access
PDF file
IZIvana Zimonjić
Ivana Zimonjić
LDLazar Radivoje Dražeta
Lazar Radivoje Dražeta
VMValentina Marinković
Valentina Marinković
TMTatjana Milošević
Tatjana Milošević
This study explored a competency-based soft-skills programme supporting evolving community pharmacy professionals’ roles and sustainable practice in Serbia. Four researchers with academic and practice backgrounds developed the programme using healthcare guidelines and the International Pharmaceutical Federation’s competency framework. The process involved defining objectives, selecting methods, designing and organising activities, accreditation, and evaluating outcomes based on the Kirkpatrick model. From January 2021 to March 2025, the “Galenika Academy” was implemented through webinars, accredited tests, onsite courses, and a mobile application. Satisfaction was assessed via a validated online questionnaire among participants attending ≥80% of sessions, following evaluation of attendance and test performance. The programme reached 5107 participants, 10,427 webinar views, and 8252 test completions. The “Galiverse” mobile app, launched in February 2023, had 5558 users by March 2025. The most attended webinar was “Burnout” (787). Average test success was 82.9%, with 95.3% for “Resilience” and 61.0% for “Team Management.” Satisfaction was 95.5% for content, 94.2% for quality, 92.3% for materials, 77.1% for the application, and 96.3% would recommend it. Among those reporting improved resilience, 96.9% believed it could positively impact pharmacy operations. Pharmacists found the programme relevant and effective. Further research is needed to evaluate its impact on practice and patient outcomes.

30 April 2025 in Research Square
Verified
Preprint
Open access
PDF file
IZIvana Zimonjić
Ivana Zimonjić
VMValentina Marinković
Valentina Marinković
DJDragana Jocić
Dragana Jocić
LDLazar Dražeta
Lazar Dražeta
MOMarina Odalović
Marina Odalović
Background: The second victim phenomenon, referring to the impact of patient safety incidents on healthcare professionals, also affects pharmacists. Dispensing errors or inadequate counselling cause anxiety, reduced motivation, and staff turnover. Support programmes for healthcare professionals have been developed, but not specifically for pharmacists. Aim: This study aimed to investigate pharmacists' perceptions of tailored education to enhance competencies in overcoming second victim phenomenon, including (i) potential impacts of such programmes, (ii) recommended content for continuous professional development and undergraduate curricula, (iii) preferred design and delivery methods, and (iv) experience with existing programmes. Method: A qualitative focus group study involved 25 community pharmacists. Data were collected using a semi-structured guide for focus group discussions and a self-reporting questionnaire. Discussions continued until data saturation. Recordings were transcribed and analysed using MAXQDA software with an inductive thematic approach. Statistical analysis examined the relationships between participation in existing programmes and outcomes. Results: Participants perceived tailored education as essential for improving crisis response, empowering individuals and profession, and enhancing pharmaceutical care. Key topics for professional development include soft skills, risk and stress management, and strengthening the role of pharmacists, while undergraduate curricula should focus on soft skills, motivation, and career development. Preferred learning methods included roundtable workshops and blended learning, with stakeholder engagement. Majority of participants (80%) attended existing support programmes, with 76% reporting improved competencies and 80% recommending the programmes to colleagues. Conclusion: Community pharmacy practitioners perceived tailored education for overcoming second victim phenomenon outcomes as essential for professional success and improving pharmaceutical care.

9 July 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
IZIvana Zimonjić
Ivana Zimonjić
LDLazar Radivoje Dražeta
Lazar Radivoje Dražeta
VMValentina Marinković
Valentina Marinković
TMTatjana Milošević
Tatjana Milošević
This study explored a competency-based soft-skills programme supporting evolving community pharmacy professionals’ roles and sustainable practice in Serbia. Four researchers with academic and practice backgrounds developed the programme using healthcare guidelines and the International Pharmaceutical Federation’s competency framework. The process involved defining objectives, selecting methods, designing and organising activities, accreditation, and evaluating outcomes based on the Kirkpatrick model. From January 2021 to March 2025, the "Galenika Academy" was implemented through webinars, accredited tests, onsite courses, and a mobile application. Satisfaction was assessed via a validated online questionnaire among participants attending ≥80% of sessions, following evaluation of attendance and test performance. The programme reached 5,107 participants, 10,427 webinar views, and 8,252 test completions. The "Galiverse" mobile app, launched in February 2023, had 5,558 users by March 2025. The most attended webinar was "Burnout" (787). Average test success was 82.9%, with 95.3% for "Resilience" and 61.0% for "Team Management." Satisfaction was 95.5% for content, 94.2% for quality, 92.3% for materials, 77.1% for the application, and 96.3% would recommend it. Among those reporting improved resilience, 96.9% believed it could positively impact pharmacy operations. Pharmacists found the programme relevant and effective. Further research is needed to evaluate its impact on practice and patient outcomes.